124 related articles for article (PubMed ID: 16363507)
1. [TLR4/MD -2-dependent recognition of H. pylori LPS during gastric inflammation].
Ishihara S; Kinoshita Y
Nihon Rinsho; 2005 Nov; 63 Suppl 11():69-74. PubMed ID: 16363507
[No Abstract] [Full Text] [Related]
2. Toll-like receptor (TLR) 2 induced through TLR4 signaling initiated by Helicobacter pylori cooperatively amplifies iNOS induction in gastric epithelial cells.
Uno K; Kato K; Atsumi T; Suzuki T; Yoshitake J; Morita H; Ohara S; Kotake Y; Shimosegawa T; Yoshimura T
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G1004-12. PubMed ID: 17855767
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori infection affects Toll-like receptor 4 expression in human gastric mucosa.
Asahi K; Fu HY; Hayashi Y; Eguchi H; Murata H; Tsujii M; Tsuji S; Tanimura H; Kawano S
Hepatogastroenterology; 2007; 54(79):1941-4. PubMed ID: 18251133
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer.
Castaño-Rodríguez N; Kaakoush NO; Pardo AL; Goh KL; Fock KM; Mitchell HM
Hum Immunol; 2014 Aug; 75(8):808-15. PubMed ID: 24929142
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori augments growth of gastric cancers via the lipopolysaccharide-toll-like receptor 4 pathway whereas its lipopolysaccharide attenuates antitumor activities of human mononuclear cells.
Chochi K; Ichikura T; Kinoshita M; Majima T; Shinomiya N; Tsujimoto H; Kawabata T; Sugasawa H; Ono S; Seki S; Mochizuki H
Clin Cancer Res; 2008 May; 14(10):2909-17. PubMed ID: 18483357
[TBL] [Abstract][Full Text] [Related]
6. Role of surfactant protein D (SP-D) in innate immunity in the gastric mucosa: evidence of interaction with Helicobacter pylori lipopolysaccharide.
Moran AP; Khamri W; Walker MM; Thursz MR
J Endotoxin Res; 2005; 11(6):357-62. PubMed ID: 16303091
[TBL] [Abstract][Full Text] [Related]
7. Molecular mimicry between Helicobacter pylori and the host.
Appelmelk BJ; Negrini R; Moran AP; Kuipers EJ
Trends Microbiol; 1997 Feb; 5(2):70-3. PubMed ID: 9108933
[TBL] [Abstract][Full Text] [Related]
8. MD-2 as the target of curcumin in the inhibition of response to LPS.
Gradisar H; Keber MM; Pristovsek P; Jerala R
J Leukoc Biol; 2007 Oct; 82(4):968-74. PubMed ID: 17609337
[TBL] [Abstract][Full Text] [Related]
9. Interplay between Helicobacter pylori and the immune system. Clinical implications.
Szczepanik M
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():15-27. PubMed ID: 17033103
[TBL] [Abstract][Full Text] [Related]
10. Soluble MD2 increases TLR4 levels on the epithelial cell surface.
Lauer S; Kunde YA; Apodaca TA; Goldstein B; Hong-Geller E
Cell Immunol; 2009; 255(1-2):8-16. PubMed ID: 18845299
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori inflammation, immunity, and vaccines.
D'Elios MM; Andersen LP
Helicobacter; 2007 Oct; 12 Suppl 1():15-9. PubMed ID: 17727455
[TBL] [Abstract][Full Text] [Related]
12. Inflammation, immunity, and vaccines for Helicobacter pylori.
D'Elios MM; Andersen LP
Helicobacter; 2009 Sep; 14 Suppl 1():21-8. PubMed ID: 19712164
[TBL] [Abstract][Full Text] [Related]
13. [The chemical structure of Helicobacter pylori lipopolysaccharide and innate immune response].
Arabski M; Koza A; Kaca W
Postepy Hig Med Dosw (Online); 2008 Jun; 62():289-96. PubMed ID: 18583952
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity.
Gewirtz AT; Yu Y; Krishna US; Israel DA; Lyons SL; Peek RM
J Infect Dis; 2004 May; 189(10):1914-20. PubMed ID: 15122529
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
16. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.
Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA
Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285
[TBL] [Abstract][Full Text] [Related]
17. Innate immune recognition of the extracellular mucosal pathogen, Helicobacter pylori.
Ferrero RL
Mol Immunol; 2005 May; 42(8):879-85. PubMed ID: 15829277
[TBL] [Abstract][Full Text] [Related]
18. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
[TBL] [Abstract][Full Text] [Related]
19. Expression of hepatitis B virus antigen and Helicobacter pylori infection in gastric mucosa of patients with chronic liver disease.
Chen NL; Bai L; Deng T; Zhang C; Kong QY; Chen H
Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):223-5. PubMed ID: 15138114
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell receptor T-lymphocytes in normal and Helicobacter pylori-infected human gastric mucosa.
O'Keeffe J; Gately CM; O'Donoghue Y; Zulquernain SA; Stevens FM; Moran AP
Helicobacter; 2008 Dec; 13(6):500-5. PubMed ID: 19166415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
